Research > Cancer

Research group of Cancer Biomarkers (GReBiC)

Number of publications
471
Publications search
  • Porcel JM; Lee YCG

    Advances in pleural diseases.

    EUROPEAN RESPIRATORY JOURNAL 63 -. .

    [doi:10.1183/13993003.00593-2024]

  • Nguyen NP; Chirila ME; Page BR; Vinh-Hung V; Gorobets O; Mohammadianpanah M; Giap H; Arenas M; Bonet M; Lara PC; Kim L; Dutheil F; Lehrman D; Montes LZ; Tlili G; Dahbi Z; Loganadane G; Blanco SC; Bose S; Natoli E; Li E; Mallum A; Morganti AG

    Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group.

    Frontiers in oncology 14 1391464-1391464. .

    [doi:10.3389/fonc.2024.1391464]

  • Valladares-Ayerbes, M; Safont, MJ; Flores, EG; García-Alfonso, P; Aranda, E; Muñoz, AML; Ferrer, EF; Nogueras, LC; Rodríguez-Salas, N; Aparicio, J; Muñoz, ML; Cáceres, PPP; Trujillo, OAC; Tocino, RV; Fernández, MS; Salud-Salvia, A; Sureda, BM; Garcia-Carbonero, R; Conesa, MAV; Vila, AL

    Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

    CLINICAL & TRANSLATIONAL ONCOLOGY -. .

    [doi:10.1007/s12094-024-03487-4]

  • Freyer, G; Martinez-Jañez, N; Kukielka-Budny, B; Ulanska, M; Bourgeois, H; Muñoz, M; Morales, S; Calero, JB; Cortesi, L; Pintér, T; Palácová, M; Cherciu, N; Petru, E; Ettl, J; de Almeida, C; Villanova, G; Raymond, R; Minh, CTT; Rodrigues, A; Cazzaniga, ME

    Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study

    BREAST 74 103681-103681. .

    [doi:10.1016/j.breast.2024.103681]

  • Martinez-Jañez, N; Ezquerra, MB; Sanchez, LMM; Carrasco, FH; Torres, AA; Morales, S; Ortega, PT; Gil, VLO; Sampedro, T; Conejero, RA; Calvo-Martinez, L; Galve-Calvo, E; López, R; de la Pena, FA; Lopez-Tarruella, S; de Araguiz, BAHF; Ruiz, LB; Cardenas, TM; Chacon, JI; Antón, FM

    First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN

    BREAST CANCER RESEARCH AND TREATMENT 206 57-65. .

    [doi:10.1007/s10549-024-07287-w]

  • García-Díaz HC; Eremiev S; Gómez-Alonso J; Veas Rodriguez J; Farriols A; Carreras MJ; Serrano C

    Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example.

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE 30 576-583. .

    [doi:10.1177/10781552231225188]

  • Recuero Díaz JL; Gatius Caldero S; Rosado Rodríguez J; Caamaño Villaverde V; Gómez de Antonio D; Tejerina E; Sánchez Moreno L; Martino González M; Moldes Rodríguez M; Abdulkader Nallib I; Ramírez Gil E; Amat Villegas I; Genovés Crespo M; García Ángel R; Sampedro Salinas C; Figueroa Almánzar S; Compañ Quilis A; Saumench Perramon R; González Pont G; Royo Crespo Í; Gambó Grasa P; García Fernández JL; Jiménez Heffernan JA; Cerón Navarro J; Prieto Rodríguez M; Porcel JM

    Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell Lung Cancer.

    ARCHIVOS DE BRONCONEUMOLOGIA 60 133-142. .

    [doi:10.1016/j.arbres.2023.12.001]

  • Liesa, L; Porcel, JM

    Bibliometric analysis of the official journals of internal medicine societies in Europe

    REVISTA CLINICA ESPANOLA 224 133-140. .

    [doi:10.1016/j.rce.2024.01.008]

  • Chaddha U; Porcel JM; Murgu SD

    Indwelling pleural catheters or chest drains for managing malignant pleural effusions: a distinction without a difference?

    EUROPEAN RESPIRATORY JOURNAL 63 -. .

    [doi:10.1183/13993003.02268-2023]

  • Bodtger, U; Porcel, JM

    TARGETing the utility of CT-guided pleural biopsy facilitated by PET-CT imaging

    EUROPEAN RESPIRATORY JOURNAL 63 -. .

    [doi:10.1183/13993003.00037-2024]

  • Gonnelli, F; Hassan, W; Bonifazi, M; Pinelli, V; Bedawi, EO; Porcel, JM; Rahman, NM; Mei, FDRC

    Malignant pleural effusion: current understanding and therapeutic approach

    Respiratory Research 25 47-47. .

    [doi:10.1186/s12931-024-02684-7]

  • Cescon DW; Hilton J; Morales Murilo S; Layman RM; Pluard T; Yeo B; Park IH; Provencher L; Kim SB; Im YH; Wyce A; Krishnatry AS; Hicks K; Zhang Q; Barbash O; Khaled A; Horner T; Dhar A; Oliveira M; Sparano JA

    A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

    CLINICAL CANCER RESEARCH 30 334-343. .

    [doi:10.1158/1078-0432.CCR-23-0133]